Diversity of the gut microbiome is associated with higher response rates for cancer patients
receiving immunotherapy but has not been investigated in patients receiving radiation …

Background The US is experiencing an epidemic of HPV + oropharyngeal cancers (OPC),
the rates and burden of which now exceed that for cervical cancer. Immunotherapy targeting …

Although the BCG vaccine offers partial protection, tuberculosis remains a leading cause of
infectious disease death, killing ∼1.5 million people annually. We developed mucosal …

Purpose Radiation therapy has direct cytotoxic effects on tumor-infiltrating lymphocytes, but
it also has immune stimulatory effects that increase immune cell infiltration. The dynamics of …

… Nookala, Ananta V. Yanamandra, Stephanie Dorta-Estremera, Geena Mathew, Rohit
Kavukuntla, Cassidy Papso, Mustapha Ahmed-Kaddar, Minsoo Kim, Jianhua Zhang, Alexandre …

High-risk human papillomavirus (HPV)–associated squamous cell carcinomas of the
oropharynx (SCCOP) are among the fastest growing cancers. After standard-of-care treatment, …

Antibiotics affect microbial diversity in the gut, leading to dysbiosis and impaired immunity.
However, the impact of antibiotics on microbial communities at other sites, such as vagina is …

Studies have demonstrated that purported biofield therapy emitted from humans can inhibit
the proliferation of cancer cells and suppress tumor growth in various cancers. We explored …

Diversity of the gut microbiome is associated with higher response rates for cancer patients
receiving immunotherapy but has not been investigated in patients receiving radiation …

Human papillomavirus (HPV)-induced cancers continue to affect millions of women around
the world, and the five year survival rate under the current standard of care for these cancers …